Triastek announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE
Volcanics Venture warmly congratulates Fangzhou on its listing on the Hong Kong Stock Exchange
GJS Robot Shines at the Shenzhen Hi-Tech Fair
GeeTest Wins Multiple Industry Awards Recognizing Corporate and Innovation Achievements
Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene
XLement product won the "Excellent Product Award" at CHTF 2022
火山石投资成员企业「方舟健客」冲刺港交所：中国最大线上慢病管理平台
Phanes Therapeutics' PT217 receives Orphan Drug Designation for small cell lung cancer from the FDA
Volcanics Venture awarded with "The Most Entrepreneur Friendly Investment Institution"
Phanes Therapeutics announces FDA IND clearance for PT199
Fourier Intelligence has received 400million in Series D funding led by SoftBank.
Volcanics Venture awarded with "Top100 Venture Capital Institutions in China "
Volcanics Venture won multiply awards
Fourier Intelligence Raises Tens of Millions in Series C+ Financing Round
RootPath raises $50m
Huleen, a note-taking mobile app, received the angel round funding from Volcanics Venture to further
Triastek Closes US$ 50 Million Series B Financing